Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials

This study has been terminated.
Information provided by:
Bukwang Pharmaceutical Identifier:
First received: August 8, 2006
Last updated: NA
Last verified: June 2006
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: March 2006
  Estimated Primary Completion Date: No date given